These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 12693735)
1. Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics. Costello-Boerrigter LC; Boerrigter G; Burnett JC Med Clin North Am; 2003 Mar; 87(2):475-91. PubMed ID: 12693735 [TBL] [Abstract][Full Text] [Related]
3. The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'. Verbrugge FH; Dupont M; Steels P; Grieten L; Swennen Q; Tang WH; Mullens W Eur J Heart Fail; 2014 Feb; 16(2):133-42. PubMed ID: 24464967 [TBL] [Abstract][Full Text] [Related]
4. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy. Díez J Eur J Heart Fail; 2017 Feb; 19(2):167-176. PubMed ID: 27766748 [TBL] [Abstract][Full Text] [Related]
6. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure]. Christ M; Ludwig N; Maisch B Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459 [TBL] [Abstract][Full Text] [Related]
7. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy]. Haller C Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022 [TBL] [Abstract][Full Text] [Related]
8. Balancing diuretic therapy in heart failure: loop diuretics, thiazides, and aldosterone antagonists. Paul S Congest Heart Fail; 2002; 8(6):307-12. PubMed ID: 12461320 [TBL] [Abstract][Full Text] [Related]
9. Rational use of diuretics in acute decompensated heart failure. Goebel JA; Van Bakel AB Curr Heart Fail Rep; 2008 Sep; 5(3):153-62. PubMed ID: 18752765 [TBL] [Abstract][Full Text] [Related]
10. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE. CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808 [TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonists in hypertension and heart failure. Mantero F; Lucarelli G Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593 [TBL] [Abstract][Full Text] [Related]
12. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782 [TBL] [Abstract][Full Text] [Related]
14. GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation. Katsurada K; Nandi SS; Zheng H; Liu X; Sharma NM; Patel KP Cardiovasc Diabetol; 2020 May; 19(1):57. PubMed ID: 32384887 [TBL] [Abstract][Full Text] [Related]
15. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention. Hensen J; Abraham WT; Dürr JA; Schrier RW Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232 [TBL] [Abstract][Full Text] [Related]